17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Duchenne muscular dystrophy (DMD) is an X-linked muscle-wasting disorder caused by mutations in the dystrophin gene, with an incidence of 1 in 3500 in new male births. Mdx mice are widely used as an animal model for DMD. However, these mice do not faithfully recapitulate DMD patients in many aspects, rendering the preclinical findings in this model questionable. Although larger animal models of DMD, such as dogs and pigs, have been generated, usage of these animals is expensive and only limited to several facilities in the world. Here, we report the generation of a rabbit model of DMD by co-injection of Cas9 mRNA and sgRNA targeting exon 51 into rabbit zygotes. The DMD knockout (KO) rabbits exhibit the typical phenotypes of DMD, including severely impaired physical activity, elevated serum creatine kinase levels, and progressive muscle necrosis and fibrosis. Moreover, clear pathology was also observed in the diaphragm and heart at 5 months of age, similar to DMD patients. Echocardiography recording showed that the DMD KO rabbits had chamber dilation with decreased ejection fraction and fraction shortening. In conclusion, this novel rabbit DMD model generated with the CRISPR/Cas9 system mimics the histopathological and functional defects in DMD patients, and could be valuable for preclinical studies.

          This article has an associated First Person interview with the first author of the paper .

          Abstract

          Summary: The DMD KO rabbit engineered by CRISPR genome editing faithfully recapitulates the DMD pathologies, and could be a valuable tool for basic and translational studies to combat this disease.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Evidence-based path to newborn screening for Duchenne muscular dystrophy.

          Creatine kinase (CK) levels are increased on dried blood spots in newborns related to the birthing process. As a marker for newborn screening, CK in Duchenne muscular dystrophy (DMD) results in false-positive testing. In this report, we introduce a 2-tier system using the dried blood spot to first assess CK with follow-up DMD gene testing. A fluorometric assay based upon the enzymatic transphosphorylation of adenosine diphosphate to adenosine triphosphate was used to measure CK activity. Preliminary studies established a population-based range of CK in newborns using 30,547 deidentified anonymous dried blood spot samples. Mutation analysis used genomic DNA extracted from the dried blood spot followed by whole genome amplification with assessment of single-/multiexon deletions/duplications in the DMD gene using multiplex ligation-dependent probe amplification. DMD gene mutations (all exonic deletions) were found in 6 of 37,649 newborn male subjects, all of whom had CK levels>2,000U/l. In 3 newborns with CK>2,000U/l in whom DMD gene abnormalities were not found, we identified limb-girdle muscular dystrophy gene mutations affecting DYSF, SGCB, and FKRP. A 2-tier system of analysis for newborn screening for DMD has been established. This path for newborn screening fits our health care system, minimizes false-positive testing, and uses predetermined levels of CK on dried blood spots to predict DMD gene mutations. Copyright © 2012 American Neurological Association.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

              About 60% of both Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) is due to deletions of the dystrophin gene. For cases with a deletion mutation, the "reading frame" hypothesis predicts that BMD patients produce a semifunctional, internally deleted dystrophin protein, whereas DMD patients produce a severely truncated protein that would be unstable. To test the validity of this theory, we analyzed 258 independent deletions at the DMD/BMD locus. The correlation between phenotype and type of deletion mutation is in agreement with the "reading frame" theory in 92% of cases and is of diagnostic and prognostic significance. The distribution and frequency of deletions spanning the entire locus suggests that many "in-frame" deletions of the dystrophin gene are not detected because the individuals bearing them are either asymptomatic or exhibit non-DMD/non-BMD clinical features.
                Bookmark

                Author and article information

                Journal
                Dis Model Mech
                Dis Model Mech
                DMM
                dmm
                Disease Models & Mechanisms
                The Company of Biologists Ltd
                1754-8403
                1754-8411
                1 June 2018
                4 June 2018
                4 June 2018
                : 11
                : 6
                : dmm032201
                Affiliations
                [1 ]Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University , Changchun, 130062, China
                [2 ]Department of Surgery, Davis Heart and Lung Research Institute, Biomedical Sciences Graduate Program, Biophysics Graduate Program, The Ohio State University Wexner Medical Center , Columbus, OH 43210, US
                Author notes
                Author information
                http://orcid.org/0000-0003-4628-7513
                http://orcid.org/0000-0001-6914-8589
                http://orcid.org/0000-0002-8202-9186
                Article
                DMM032201
                10.1242/dmm.032201
                6031364
                29871865
                efef8946-cf30-454e-b76e-563633ae10e5
                © 2018. Published by The Company of Biologists Ltd

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 25 September 2017
                : 18 April 2018
                Funding
                Funded by: National Heart, Lung, and Blood Institute, http://dx.doi.org/10.13039/100000050;
                Award ID: R01HL116546
                Funded by: National Institute of Arthritis and Musculoskeletal and Skin Diseases, http://dx.doi.org/10.13039/100000069;
                Award ID: R01AR064241
                Categories
                Research Article

                Molecular medicine
                crispr,cardiomyopathy,dystrophin,gene editing,muscular dystrophy,rabbit
                Molecular medicine
                crispr, cardiomyopathy, dystrophin, gene editing, muscular dystrophy, rabbit

                Comments

                Comment on this article